Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Mar 5:S1535-6108(26)00108-X.
doi: 10.1016/j.ccell.2026.02.010. Online ahead of print.

A tumor-associated photoreceptor signature unifies distinct central nervous system malignancies

Affiliations
Free article

A tumor-associated photoreceptor signature unifies distinct central nervous system malignancies

Brian L Gudenas et al. Cancer Cell. .
Free article

Abstract

Pineoblastoma is a clinically aggressive childhood brain tumor composed of distinct molecular subgroups with divergent driver genes, demographics, and clinical outcomes. To identify developmental origins and mechanisms governing disease pathogenesis, we derive single-cell transcriptomes from pineal parenchymal tumors, aligning malignant cells with developmental counterparts to retrace cellular origins. Integrative computational analyses map pineoblastoma origins to transient, cycling pinealocyte progenitors during development. Lineage-specific perturbation of suspected drivers in the early pineal gland yields preclinical models representative of consensus molecular subgroups. Multi-omic characterization of patient tumors and these models uncover a tumor-associated photoreceptor signature (TAPS) common to pineoblastoma, retinoblastoma, and Group 3 medulloblastoma. Transcriptional activity of this signature within respective cellular origins establishes a developmental basis for molecular similarities between entities. Photoreceptor signature constituents are selective dependencies across these anatomically distinct central nervous system malignancies, motivating future studies evaluating developmentally encoded programs of malignancy as potential therapeutic liabilities.

Keywords: central nervous system cancers; developmental origins; genetic dependencies; genetically engineered mouse models; medulloblastoma; photoreceptor; pineal gland; pineoblastoma; retinoblastoma; single-cell genomics.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests M.G.F. is a consultant for Twentyeight-Seven Therapeutics and Blueprint Medicines. F.J.S. is the CEO of Sox Therapeutics. The remaining authors declare no competing interests.

LinkOut - more resources